Skip to content
MedsAcross

Manufacturer

Ipca Laboratories

Pharmaceutical manufacturer based in India
Indian manufacturerIndia
Products listed
24
Molecules
8
Therapy areas
4

Ipca Laboratories is a pharmaceutical manufacturer based in India. MedsAcross lists 24 of its products across 8 molecules, each with registers, packs and availability for export supply to licensed buyers.

Country
India
Indian manufacturer
Yes
Also listed as
Ipca Laboratories Limited
US FDA labeler
YesSource: openFDA NDC directory

Source from this manufacturer

We supply Ipca Laboratories products through licensed channels, with the documents your regulator needs.

Cardiology

13 presentations

Cardiology overview
MedicineActive ingredientRegisterAvailability
Atenolol 100 mg tabletOralGeneric nameAtenololUS FDAAvailable on request
Atenolol 25 mg tabletOralGeneric nameAtenololUS FDAAvailable on request
Atenolol 50 mg tabletOralGeneric nameAtenololUS FDAAvailable on request
Chlorthalidone 25 mg tabletOralGeneric nameChlorthalidoneUS FDAAvailable on request
Chlorthalidone 50 mg tabletOralGeneric nameChlorthalidoneUS FDAAvailable on request
Furosemide 20 mg tabletOralGeneric nameFurosemideUS FDAAvailable on request
Furosemide 40 mg tabletOralGeneric nameFurosemideUS FDAAvailable on request
Furosemide 80 mg tabletOralGeneric nameFurosemideUS FDAAvailable on request
Propranolol 10 mg tabletOralGeneric namePropranololUS FDAAvailable on request
Propranolol 20 mg tabletOralGeneric namePropranololUS FDAAvailable on request
Propranolol 40 mg tabletOralGeneric namePropranololUS FDAAvailable on request
Propranolol 60 mg tabletOralGeneric namePropranololUS FDAAvailable on request
Propranolol 80 mg tabletOralGeneric namePropranololUS FDAAvailable on request

Gastroenterology

6 presentations

Gastroenterology overview
MedicineActive ingredientRegisterAvailability
Metoclopramide 10 mg tabletOralGeneric nameMetoclopramideUS FDAAvailable on request
Metoclopramide 5 mg tabletOralGeneric nameMetoclopramideUS FDAAvailable on request
Ondansetron 4 mg tabletOralGeneric nameOndansetronUS FDAAvailable on request
Ondansetron 4 mg orally disintegrating tabletOralGeneric nameOndansetronUS FDAAvailable on request
Ondansetron 8 mg tabletOralGeneric nameOndansetronUS FDAAvailable on request
Ondansetron 8 mg orally disintegrating tabletOralGeneric nameOndansetronUS FDAAvailable on request

Rheumatology

4 presentations

Rheumatology overview
MedicineActive ingredientRegisterAvailability
Etodolac 200 mg capsuleOralGeneric nameEtodolacUS FDAAvailable on request
Etodolac 300 mg capsuleOralGeneric nameEtodolacUS FDAAvailable on request
Etodolac 400 mg tabletOralGeneric nameEtodolacUS FDAAvailable on request
Etodolac 500 mg tabletOralGeneric nameEtodolacUS FDAAvailable on request

Malaria

1 presentation

Malaria overview
MedicineActive ingredientRegisterAvailability
Hydroxychloroquine 200 mg tabletOralGeneric nameHydroxychloroquineUS FDAAvailable on request

Molecules made

Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.

Source from Ipca Laboratories

Send a request for any of these products. We confirm the licensed source, documents and lead time.